Atea Pharmaceuticals: Pay

Atea Pharmaceuticals paid its 5 named executives $9.7M in total in FY2025 (Dec). CEO Jean-Pierre Sommadossi, PhD was paid $3.4M of that.

Pay$100 in the stock at the end of FY20 → $9
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Jean-Pierre Sommadossi, PhDPresident, Chief Executive Officer and Chairman of the Board
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Janet Hammond, MD, PhDChief Development Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Andrea CorcoranChief Financial Officer, Executive Vice President, Legal
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Maria Arantxa Horga, MDChief Medical Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
John VavrickaChief Commercial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 5 peers with pay on file was $3.7M. The CEO of Atea Pharmaceuticals was paid $3.4M, 8% below the median.

  1. 1Scholar Rock Holding
  2. 2Vir Biotechnology
  3. 3Replimune Group
  4. 4Atea Pharmaceuticals
  5. 5Gossamer Bio
  6. 6Arbutus Biopharma
  7. 789bio, Inc.Not disclosed
  8. 8Alector, Inc.Not disclosed
  9. 9Allakos Inc.Not disclosed
  10. 10AlloVir, Inc.Not disclosed
  11. 11Anaptys Bio, Inc.Not disclosed
  12. 12Annexion, Inc.Not disclosed
  13. 13Arcturus Therapeutics HoldingsNot disclosed
  14. 14Assembly Biosciences, Inc.Not disclosed
  15. 15Chimerix, Inc.Not disclosed
  16. 16Enanta Pharmaceuticals, Inc.Not disclosed
  17. 17Inozyme Pharma, Inc.Not disclosed
  18. 18Invivyd, Inc.Not disclosed
  19. 19Kodiak Sciences Inc.Not disclosed
  20. 20Y-mABs Therapeutics, Inc.Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.